BORTOLUZZI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 11.770
AS - Asia 7.472
EU - Europa 3.399
SA - Sud America 1.208
AF - Africa 472
Continente sconosciuto - Info sul continente non disponibili 467
OC - Oceania 86
AN - Antartide 1
Totale 24.875
Nazione #
US - Stati Uniti d'America 11.303
SG - Singapore 2.499
CN - Cina 1.374
IT - Italia 1.153
BR - Brasile 818
VN - Vietnam 665
HK - Hong Kong 619
BD - Bangladesh 478
DE - Germania 429
GB - Regno Unito 383
ID - Indonesia 329
FR - Francia 287
IN - India 269
JP - Giappone 254
EG - Egitto 236
TR - Turchia 227
FI - Finlandia 219
CA - Canada 201
UA - Ucraina 177
RU - Federazione Russa 167
MX - Messico 164
IQ - Iraq 163
AR - Argentina 103
EC - Ecuador 96
NL - Olanda 95
SE - Svezia 89
PL - Polonia 83
PH - Filippine 82
AU - Australia 73
ZA - Sudafrica 73
PK - Pakistan 71
ES - Italia 63
SA - Arabia Saudita 59
IR - Iran 56
MY - Malesia 53
TW - Taiwan 51
CO - Colombia 50
AT - Austria 38
VE - Venezuela 35
PE - Perù 34
IE - Irlanda 33
KE - Kenya 33
CL - Cile 32
KR - Corea 32
BE - Belgio 29
UZ - Uzbekistan 26
DZ - Algeria 24
BO - Bolivia 21
HU - Ungheria 20
JM - Giamaica 20
NG - Nigeria 20
TH - Thailandia 20
CR - Costa Rica 19
MA - Marocco 19
TN - Tunisia 19
JO - Giordania 18
RO - Romania 17
CZ - Repubblica Ceca 16
IL - Israele 16
LT - Lituania 15
AE - Emirati Arabi Uniti 13
NZ - Nuova Zelanda 13
GR - Grecia 12
PT - Portogallo 12
CH - Svizzera 11
HN - Honduras 11
KZ - Kazakistan 11
LB - Libano 10
NP - Nepal 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
LY - Libia 9
PS - Palestinian Territory 9
PY - Paraguay 9
KW - Kuwait 8
NO - Norvegia 8
UY - Uruguay 8
LK - Sri Lanka 7
DO - Repubblica Dominicana 6
NI - Nicaragua 6
OM - Oman 6
AL - Albania 5
MM - Myanmar 5
PR - Porto Rico 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
ET - Etiopia 4
GT - Guatemala 4
HR - Croazia 4
KH - Cambogia 4
LV - Lettonia 4
PA - Panama 4
SN - Senegal 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BF - Burkina Faso 3
BH - Bahrain 3
CG - Congo 3
Totale 24.340
Città #
Ashburn 1.516
Singapore 1.449
Fairfield 893
San Jose 806
Santa Clara 636
Hong Kong 577
Woodbridge 569
Council Bluffs 490
Beijing 468
Dallas 424
Houston 373
Seattle 354
Chandler 303
Cambridge 296
Wilmington 285
Los Angeles 275
Ho Chi Minh City 234
Ann Arbor 224
New York 224
Tokyo 203
Jakarta 191
Jacksonville 174
Hanoi 162
Lauterbourg 135
Helsinki 131
Ferrara 120
Princeton 115
Izmir 109
Milan 108
Munich 104
Nanjing 85
Shanghai 84
Baghdad 81
São Paulo 77
Orem 71
San Diego 71
Chicago 70
Warsaw 69
Cairo 68
London 67
Toronto 65
Rome 62
Buffalo 60
Mexico City 60
Alexandria 59
Montreal 57
Atlanta 52
Frankfurt am Main 49
Brooklyn 45
Bologna 44
Boston 43
Denver 42
Phoenix 42
Boardman 39
The Dalles 38
Franklin 37
San Francisco 37
Naples 35
Stockholm 35
Turku 34
Hefei 33
Quito 32
Rio de Janeiro 32
Da Nang 30
Dearborn 30
Haiphong 29
Johannesburg 29
Nuremberg 29
Tanta 29
Poplar 27
Chennai 26
Falkenstein 26
Lappeenranta 26
Manchester 26
Nairobi 26
Ankara 25
Moscow 25
Sydney 25
Dublin 24
Redwood City 24
Tianjin 24
Amsterdam 23
Riyadh 23
Shenyang 23
Tashkent 23
Brussels 22
Guayaquil 22
Mumbai 22
Istanbul 21
Nanchang 21
Verona 21
Medan 20
Athens 19
Bengaluru 19
Bremen 19
Miami 19
Budapest 18
Charlotte 18
Jiaxing 18
Kuala Lumpur 18
Totale 14.592
Nome #
Systemic lupus erythematosus: one year in review 2023 976
One year in review 2022: systemic lupus erythematosus 473
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 449
The Italian society for rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis 336
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 300
Novel insights into the management of rheumatoid arthritis: one year in review 2022 299
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 288
Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound 280
Novel insights into the management of rheumatoid arthritis: one year in review 2023 277
Osteoarthritis and its management - Epidemiology, nutritional aspects and environmental factors 274
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 263
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: Analysis of a large monocentric cohort with a long-term follow-up 259
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 248
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 246
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 246
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 230
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 229
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology 225
One year in review 2020: systemic lupus erythematosus 224
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 221
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center 218
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET 217
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 217
Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study 215
Biological and synthetic target DMARDs in psoriatic arthritis 212
Altered expression and function of P2X7 receptorin patients affected by Systemic Lupus Erythematosus (SLE) 211
The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatic 207
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 205
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 203
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study 201
PHARMACOLOGICAL ROLE OF A2A ADENOSINE RECEPTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS, CLINICAL AND LABORATORY CORRELATIONS 200
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 200
How I treat patients with adult onset Still's disease in clinical practice 199
Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus 199
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 199
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 196
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 195
One year in review 2021: systemic lupus erythematosus 193
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 185
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 184
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 183
Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus 182
Overlap fra neuro-LES e sindromi demielinizzanti 181
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 181
Systemic lupus erythematosus: one year in review 2024 180
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 180
Italian Society of Rheumatology recommendations for the management of gout 177
Italian society for Rheumatology recommendations for the management of hand osteoarthritis 175
Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides 174
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 173
SNP (1513A > C AND 489C > T) OF P2X7 RECEPTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH SEROSITIS 172
Colour Duplex Ultrasonography in the Diagnosis and Management of Giant Cell Arteritis 172
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 169
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 165
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 164
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 162
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 162
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 161
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 160
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 158
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 156
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 156
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 155
Comment on: Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: Time to untie the Gordian knot? 154
Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study 154
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 153
Systemic lupus erythematosus: State of the art on clinical practice guidelines 152
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 151
Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 150
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 149
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 149
One year in review 2018: novelties in the treatment of rheumatoid arthritis 146
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 146
COLOR DOPPLER ULTRASONOGRAPHY IN THE DIAGNOSIS AND MANAGEMENT OF GIANT CELL ARTERITIS. 145
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 145
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 144
Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus 142
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 139
Neurologic Involvement in Rheumatic Diseases 138
Adenosine and adenosine receptors in rheumatoid arthritis 138
Improved pregnancy outcome in patients with Rheumatoid Arthritis who followed an ideal clinical pathway 136
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 135
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 134
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 133
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 132
The Italian society for rheumatology clinical practice guidelines for rheumatoid arthritis 131
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products 129
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 128
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 127
Systemic lupus erythematosus: one year in review 2025 125
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 125
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 125
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment 122
Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept 120
Involvement of the Inconstant Bursa of the Fifth Metatarsophalangeal Joint in Psoriatic Arthritis: A Clinical and Ultrasonographic Study 119
The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout 119
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus:experience from a tertiary referral centre. 118
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 117
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 117
The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients 116
Totale 19.300
Categoria #
all - tutte 116.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 406
Totale 117.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.082 0 99 61 50 43 49 86 97 50 68 83 396
2022/2023786 118 95 34 89 97 72 37 54 78 18 53 41
2023/20241.120 49 56 22 11 81 39 24 107 40 183 167 341
2024/20254.591 172 227 454 258 490 457 160 214 756 541 490 372
2025/202611.493 887 431 1.066 1.176 1.537 688 1.117 666 1.107 1.295 946 577
2026/20271.434 721 713 0 0 0 0 0 0 0 0 0 0
Totale 24.875